Date Filed | Type | Description |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2017 |
SC 13G/A
| APPLIED GENETIC TECHNOLOGIES CORP reports a 0% stake in Applied Genetic Techno Corp |
02/14/2017 |
SC 13G/A
| Axovant Sciences Ltd. reports a 0% stake in Axovant Sciences Ltd. |
02/14/2017 |
SC 13G/A
| ASSEMBLY BIOSCIENCES, INC. reports a 0% stake in Assembly Biosciences, Inc. |
02/14/2017 |
SC 13G/A
| AQUINOX PHARMACEUTICALS, INC reports a 0% stake in Aquinox Pharmaceuticals, Inc. |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/14/2017 |
SC 13G/A
| Sage Therapeutics, Inc. reports a 0% stake in Sage Therapeutics, Inc. |
02/14/2017 |
SC 13G/A
| ESPERION THERAPEUTICS INC reports a 0% stake in Esperion Therapeutics Inc New |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/14/2017 |
SC 13G/A
| Quotient Ltd reports a 0% stake in Quotient Limited |
02/14/2017 |
SC 13G/A
| Wright Medical Group N.V. reports a 0% stake in Wright Medical Group NV |
02/14/2017 |
SC 13G/A
| SUNESIS PHARMACEUTICALS INC reports a 0% stake in Sunesis Pharmaceuticals, Inc. |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/14/2017 |
SC 13G/A
| Zeltiq Aesthetics Inc reports a 0% stake in Zeltiq Aesthetics, Inc. |
02/14/2017 |
SC 13G/A
| Sientra, Inc. reports a 0% stake in Sientra, Inc. |
02/14/2017 |
SC 13G/A
| Visium Asset Management, LP reports a 0% stake in Ascendis Pharma A/S |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/14/2017 |
SC 13G/A
| Pacira Pharmaceuticals, Inc. reports a 0% stake in Pacira Pharmaceuticals, Inc. |
02/14/2017 |
SC 13G/A
| BIO BLAST PHARMA LTD. reports a 0% stake in Bio Blast Pharma Ltd. |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/14/2017 |
SC 13G/A
| Lipocine Inc. reports a 0% stake in Lipocine Inc. |
02/14/2017 |
SC 13G/A
| LA JOLLA PHARMACEUTICAL CO reports a 0% stake in La Jolla Pharmaceutical Company |
02/14/2017 |
SC 13G/A
| Health Insurance Innovations, Inc. reports a 0% stake in Health Insurance Innovations, Inc. |
02/14/2017 |
SC 13G/A
| Enzymotec Ltd. reports a 0% stake in Enzymotec Ltd. |
02/14/2017 |
SC 13G/A
| SUNOVION CNS DEVELOPMENT CANADA ULC reports a 0% stake in Cynapsus Therapeutics Inc. |
02/14/2017 |
SC 13G/A
| Visium Asset Management, LP reports a 0% stake in NephroGenex, Inc. |
02/14/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/14/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
08/12/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
07/21/2016 |
SC 13G/A
| Quotient Ltd reports a 0% stake in Quotient Limited |
05/16/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
|